75N93018F00009

IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	NATIONAL INSTITUTES OF HEALTH NIAID
NAICS	541712
PSC	AN86 — AIDS RESEARCH - MANAGEMENT AND SUPPORT
Parent award / vehicle	HHSN272201700010I
Set-aside	Not reported
Pricing type	COST PLUS FIXED FEE
Obligations	$12.9M
Current contract value	$12.9M
Potential contract value / ceiling	$12.9M
Start date	Aug 9, 2018
Current end date	Dec 31, 2031
Potential end date	Dec 31, 2031
Latest award activity	Mar 30, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Mar 30, 2026	P00011	$495.0K	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
May 1, 2025	P00010	$180.6K	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Nov 2, 2023	P00009	$0	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Nov 1, 2023	P00008	$0	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Mar 15, 2023	P00007	$182.2K	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Mar 16, 2022	P00006	$0	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Feb 19, 2021	P00005	$741.2K	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Jun 3, 2020	P00004	$470.0K	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Sep 11, 2019	P00003	$1.9M	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Aug 20, 2019	P00002	$-310.8K	NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Apr 30, 2019	P00001	$5.2M	IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES
Aug 9, 2018	0	$4.2M	IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT- CGMP MANUFACTURING OF PGT121 AND PGDM1400 ANTIBODIES

Estimated positioning window

Dec 31, 2030 – Jun 30, 2031

Recompete signal:

55/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 55/100. Available recorded signals: 50 points.

Contract end 2031-12-31 (1893 days from calculation): +5 points
13 historical awards in this buyer and category group: +15 points
12 recorded award transactions: +10 points
Latest award action: 2026-03-30: +5 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +10 points
Linked official forecast: +0 points
Calculated on: 2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.